Yuki Takamatsu has been accepted for AMED 2022 Establishment of the research base for BSL-4 facility and capacity building of researchers on category I (highly pathogenic pathogens)
Yuki Takamatsu
Yuki Takamatsu has been accepted for AMED 2022 Establishment of the research base for BSL-4 facility and capacity building of researchers on category I (highly pathogenic pathogens)
